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Abstract. Although subjective cognitive impairment (SCI) is increasingly recognized clinically and in research as a risk
factor for mild cognitive impairment and dementia (particularly Alzheimer’s disease), it is etiologically heterogeneous
and potentially treatable. Compared to mild cognitive impairment and Alzheimer’s disease, SCI however remains poorly
characterized with debate continuing regarding its clinical relevance. The primary aim of this study was to improve the
characterization of SCI within the general public by investigating functions sometimes omitted clinically or in research, namely
visual attention-related information processing speed (RT) and its intra-individual variability (IIVRT), general cognition,
depression, anxiety, memory, quality of life (QOL), and neuroticism. Compared to individuals without SCI, those with SCI
were more likely to reveal higher scores of anxiety, depression, and neuroticism and poorer perceived physical, psychological,
and environmental QOL. Within-group analysis identified no significant relationships between any of the above variables for
the non-SCI group whereas for the SCI group, poorer Cognitive Change Index scores were significantly correlated with slower
RT, raised IIVRT, poorer memory, negative affective symptoms, higher neuroticism scores, and poorer QOL. This indicates
that reports of perceived memory changes in SCI can also be associated with other characteristics, namely objectively
measured detrimental change in other aspects of brain function and behavior. This outcome emphasizes the importance of
a multi-function approach to characterizing and understanding SCI. Thus, although the effect of RT and IIVRT is not strong
enough to differentiate SCI from non-SCI at group level, slowing and raised IIVRT do appear to characterize some people
with SCI.
Keywords: Anxiety, dementia, depression, memory, neuroticism, quality of life, reaction time, subjective cognitive impair-
ment, visual attention
INTRODUCTION
Subjective cognitive impairment (SCI) is defined
clinically as perceived changes in memory and cogni-
tion that individuals report in the absence of objective
∗Correspondence to: Dr. Amy Jenkins, College of Human and
Health Sciences, Centre for Innovative Ageing, Haldane, Swansea
University, Singleton Park, Swansea, SA2 8PP, UK. Tel.: +44 1792
60 4720; E-mail: A.Jenkins@Swansea.ac.uk.
evidence of abnormality [1]. SCI is increasingly rec-
ognized as a risk factor for mild cognitive impairment
(MCI) and dementia (particularly Alzheimer’s dis-
ease [AD]) compared to demographically matched
healthy adults free of SCI (hazard ratio 4.5; 95% CI
1.9–10.3) [2, 3]. Nevertheless, as in MCI, SCI appears
etiologically heterogeneous. Although for some indi-
viduals, SCI may represent the outer limits of the
normal aging process, or what is in fact normal aging
ISSN 1387-2877/19/$35.00 © 2019 – IOS Press and the authors. All rights reserved
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for a particular individual with changes often consid-
ered to be ‘senior moments’ [4], a variety of risk and
causal factors for SCI continue to be reported. These
include age [5], low educational level [6], depres-
sion [7, 8], anxiety [9], chronic fatigue [10], whiplash
injuries [11], schizophrenia [12], bipolar disorder
[13], obsessive compulsive disorder [14], epilepsy
[15], multiple sclerosis [16], stroke [17], fibromyal-
gia [18], sleep apnea [19], medication side effects
[2], menopause [20], and thyroid dysfunction [21].
Such evidence indicates that some causes of SCI are
potentially treatable and may not be related to neu-
rodegenerative disease [4, 22] and that the factors
contributing to SCI may be more varied and complex
than previously envisaged. Furthermore, irrespective
of etiology, SCI can detrimentally influence quality of
life (QOL), self-perceived health [23, 24], perceived
workplace performance and restrict social activities
and mobility (e.g., driving a car) [25]. Despite such
potentially detrimental associations and irrespective
of etiology, SCI remains poorly characterized with
respect to the integrity of a wide array of brain
functions and with debate also continuing regard-
ing its clinical, research, and everyday relevance
[26–28]. It is clear therefore that further exploration to
identify causality, characteristics, consequences, pos-
sible interventions, and required support [25], factors
indicative of potentially reversible causes or neurode-
generative etiology, is imperative.
Information processing speed and intra-individual
variability
At present, by definition, SCI is characterized in
both clinical and research forums by the absence of
significant deficits in objectively measured aspects
of cognitive function such as memory, visuo-
constructional skills, and executive function, namely
those brain functions assessed by tools such as the
Montreal Cognitive Assessment (MoCA) [29]. This
focus on the functional integrity of a relatively narrow
range of brain function in SCI means that its poten-
tial detrimental effect upon ‘real life’, other brain
functions, and medical and psychological health
may be underestimated or undetected by clinicians,
researchers, and the general public [30]. Previous
research has shown that MCI, vascular cognitive
impairment, and AD (all of which may reveal SCI as a
prodromal stage) can be characterized by significant
abnormality in some aspects of attentional function
and attention-related reaction time (RT) and its intra-
individual variability (IIVRT) [30–42]. RT and IIVRT
are associated with brain white matter integrity [36],
poorer daily activity levels and quality of life [43–49].
Therefore, one of the aims of this study is to exam-
ine such function in SCI. Evidence of changes in
such function in SCI can be expected to improve our
understanding of factors contributing to the signs and
symptoms of SCI.
A challenge when investigating SCI and the com-
parison of study outcome is the associated lack of
consensus related to its concept and terminology [21].
However, subjective cognitive decline (SCD), related
more specifically to the neurodegenerative decline
associated with AD, is increasingly described clin-
ically and in research [21]. SCI was examined in
the present study in order to investigate the wider
concept of perceived changes in a wide range of eti-
ologies not specifically related to neurodegeneration,
such as anxiety and mood and thus intervention for
potentially reversible causes.
Furthermore, despite the fact that previous stud-
ies have tended to recruit people living with SCI
with a formal diagnosis from memory services (i.e.,
received a clinical diagnosis of SCI), not everyone
perceiving detrimental changes in cognitive function
seeks medical attention and thus formal assessment
[50, 51]. Such individuals may represent a sizeable
proportion of community dwelling older adults [25,
50]. In order to redress this imbalance, SCI was inves-
tigated in those who had not been in contact with
memory services. This study also extends previous
work examining RT and IIVRT in relation to perceived
memory changes in older adults [49, 52, 53].
SCI and anxiety, depression, quality of life,
neuroticism, and memory
Although debate continues with respect to cause
and effect, increasing evidence is indicative of links
between SCI and anxiety, depression, the reporting of
health problems, lower self-efficacy, less perceived
control of potential difficulties in life, and higher
scores on neuroticism, poorer QOL [9, 23, 24, 54–57,
64, 65], and links between anxiety, attention, and
RT [25, 55, 58–63]. These factors will therefore be
further investigated in this study. Furthermore, as
a relationship between objectively identifiable cog-
nitive impairment (i.e., MCI and/or AD) and the
personality trait neuroticism has frequently been
identified in previous research (e.g., [66–69]), with
some evidence that it acts as a mediating factor
between memory complaints and physical and psy-
chological health problems [54], neuroticism will
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also be included in the investigation of SCI in the
present study.
Study aims
The aim of the current study was to further char-
acterize SCI (in the general public) with respect to
information processing speed (RT) and its IIVRT, and
with respect to visual and verbal memory function,
general objectively measured cognitive function-
ing, anxiety, depression, QOL, and neuroticism. We
hypothesized the following: RT will be slower and
IIVRT greater in individuals with compared to with-
out SCI and that scores of general cognitive function,
QOL, memory (visual and verbal) will be poorer, and
scores of neuroticism, depression, and anxiety worse,
in SCI.
METHODS
Participants
An opportunity sample methodology was used.
Males (N = 24) and females (N = 75) aged 55–65
years were recruited from the general public liv-
ing in South Wales, UK (Number of participants
[N] = 99; mean [M] age = 60.43 years, standard devi-
ation [SD] = 2.96). Inclusion criteria: general public
aged 55–65, and from a self-reported perspective, in
good general medical and mental health. Exclusion
criteria: a clinical diagnosis of MCI or dementia (self-
reported medical diagnosis), self-report of decline in
cognitive ability which can be explained by a psychi-
atric or neurological disease, previous head injury,
medical disorder, medication (prescribed and non-
prescribed), or substance use. A further exclusion
factor was a visit to their general practitioner (GP)
or memory services about memory concerns. Par-
ticipants were recruited via advertisement on social
media, group email (i.e., 50+ Network), posters, etc.
Older adults aged 55–65 years were recruited in order
to represent the typical age-range through which SCI
presents. This study was approved by Swansea Uni-
versity ethics review boards and written informed
consent was obtained from all participants.
Battery of measures
Mean education level, ethnicity, employment
status/level, and family history are presented in
(Table 1). The test battery comprised: Cognitive
Change Index (Self report) (CCI-S) and the Cognitive
Change Index (Informant report) (CCI-I) to measure
SCI symptoms [71]; The World Health Organiza-
tion Quality of Life (WHOQOL-BREF) (shortened
version of the WHOQOL-100) [72]; Hospital Anx-
iety and Depression Scale (HADS) [73]; The Big
Five Inventory (BFI) to measure neuroticism [74];
Montreal Cognitive Assessment (MoCA) [29]; The
Rey Osterrieth Complex Figure (ROCF) to measure
visual memory [75]; The Hopkins Verbal Learning
Test (HVLT) to measure verbal memory [76]; The
National Adult Reading Test (NART) to measure pre-
dicted IQ [77]; Trails A (TMT A) and Trails B (TMT
B) [52]; and the adapted Multi-Item Localization task
(MILO) [53].
Figure 1 is a schematic example of a trial from
the tablet-based implementation of MILO which was
employed in the current study [78]. The participants
needed to touch each virtual pool ball from one to
eight in ascending order as quickly, but as accurately
as possible. The advantages of computer-based test
presentation in comparison to paper-and-pencil tests
include the recording of reaction times for each item,
rather than basic completion overall such as that in
the TMT (e.g., see [79]), and the capacity to investi-
gate spatial patterns of search organization (e.g., see
[80]). Additionally, the MILO task makes it possible
to easily manipulate the sequence type (e.g., digits,
letters, or both) and sequence behavior (e.g., items
vanishing or remaining, sequence position remain-
ing fixed or shuffling between responses), in order
to investigate the temporal context of visual search
[53]. Therefore, a task such as this could potentially
be employed in a clinical situation, providing infor-
mation about RT speed and variability and attention
processing, and additional features of higher level,
cognitive processing. For this study, a fixed sequence
of the digits one to eight was used, and the display
was configured so that items vanished when touched.
The additional sequences (i.e., shuffling) were not
used because only a simple measure of information
processing time (RT) and IIVRT that did not take too
long to complete was required, thus mimicking the
limited time a clinician would have to use such a test
in real life.
The sample was split based on their CCI-S scores
(CCI-S) (i.e., the SCI group and the non-SCI group)
in order to determine any between-group differences
(i.e., between SCI and non-SCI) or within-group rela-
tionships. The CCI measure has one set of cut-off
values to use as a method of grouping, which are the
ones used within the well-established Alzheimer’s
Disease Neuroimaging Initiative (ADNI) study [81].
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Table 1
Participant characteristics in both the SCI and the non-SCI group
SCI Non-SCI Pearson Chi Square Test Mann-Whitney Test results of
results of the corresponding the corresponding categories
categories within the SCI within the SCI and non-SCI
and non-SCI group group
Total N 47 52 – –
Age mean (SD) [y] 60.34 (2.71) 60.52 (3.20) – NS
Gender N (%) 35 (74.5) Female; 12 (25.5) Male 40 (76.9) Female; 12 (23.1) Male NS –
Years in FT Education mean (SD) 14.26 (2.96) 15.15 (2.97) – NS
Ethnicity group N (%) Welsh – 31 (66) Welsh – 35 (67.3) NS –
English – 8 (17) English – 6 (11.5) –
British/other – 8 (17) British/other – 11 (21.2) –
Employment status N (%) Retired or unemployed – 23 (49) Retired or unemployed – 22 (42.3) NS –
Employed or self-employed Employed or self-employed –
(full time) – 15 (32) (full time) – 18 (34.63)
Employed or self-employed Employed or self-employed –
(part time) – 9 (19.1) (part time) – 12 (23.08)
Employment level N (%) Supervisor – 12 (25.5) Supervisor – 11 (21.2) NS –
Manager – 19 (40.4) Manager – 27 (51.9) –
None – 16 (34.0) None – 14 (26.9) –
Family history of cognitive Yes (maternal) – 18 (38.3) Yes (maternal) – 20 (38.5) NS –
impairment N (%) Yes (paternal) – 1 (2.1) Yes (paternal) – 6 (11.5) –
None – 28 (59.6) None – 26 (50.0) –
CCI-S mean (SD) 27.62 (7.45) 15.04 (2.17) – U = 1.50 (Z = –8.57), p< 0.001)
Cohen’s effect size: –0.86 Large
CCI-I mean (SD) 22.26 (9.49) 15.29 (4.08) – U = 586.00 (Z = –4.49), p< 0.001)
Cohen’s effect size: –0.45 Medium
NART errors mean (SD) 11.55 (7.82) 9.31 (6.84) – NS
∗NS, not significant.
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Fig. 1. The Multi-Item Localization task (MILO).
They are the only validated cut-off values, but anal-
ysis in this study using the full-scale scores yielded
the same pattern of results. These cut-offs are based
on the first 12 CCI items (out of 20) which relate to
perceived memory concerns. Therefore, individuals
are believed to be experiencing memory concerns if
they score 20 or above on the first 12 items of the
CCI-S.
Statistical analysis
MILO generates data-rich results due to its
multiple-trial format, thus individual RT values can
be provided for each item. MILO can for instance
provide data relating to the time taken to touch the
first virtual pool ball (RT1), also the cumulative time
it takes to touch the second pool ball (RT2) and
so on, until all eight virtual pool balls have been
touched (overall time is RT8). Within the current
study, the measure of how quickly an individual
touches all eight balls and completes the trial (RT8)
was employed within the statistical analysis. As men-
tioned earlier, in this study, there were 30 trials in
the MILO test. Therefore, the median value of RT8
was calculated for the statistical analysis of between-
group differences and within-group correlations. The
IIVRT in relation to these 30 trials was also calcu-
lated and statistically analyzed as interquartile range
(IQR).
Overall, based on Kolmogorov-Smirnov analy-
sis the data (i.e., on the CCI, TMT A, TMT B,
MILO, MoCA, HVLT, ROCF, WHOQOL-BREF,
HADS, and the BFI) were not normally dis-
tributed despite score transformations, therefore
non-parametric analysis was applied. This lack of
normality can be typical of such studies and therefore
the use of non-parametric tests is common (e.g., see
[31, 32]). To determine group differences (between
the SCI and non-SCI group), the Mann-Whitney
test was employed for continuous data and the Chi
Square test was employed for categorical data. Fur-
thermore, correlations (within-group relationships)
between all test battery scores were analyzed using
non-parametric Spearman’s correlation coefficient.
Due to the multiple comparisons being investigated
in some of the correlational analyses, the Bonferroni
correction method was used in order to control for
the possibility of type-one errors.
RESULTS
Hypothesized a priori predictions were made and
therefore one-tailed analyses were run and reported
below. For completeness the analysis at a two-tailed
level was also carried out, but there were only scant
and minor differences between these two sets of anal-
yses.
As can be seen in (Table 1), no significant partic-
ipant characteristic group differences (i.e., age and
years in education) were identified apart from for
the CCI scores (which was the means by which the
groups were divided [CCI-S]) [71].
Figure 2 (non-SCI group) shows the distribution
of scores on the CCI-S measure from 10 (lowest pos-
sible score) to 19 (highest possible score before the
SCI group cut-off score of 20). Figure 3 (SCI group)
shows the distribution of scores on the CCI-S mea-
sure from 20 (lowest possible score cut-off value) to
60 (highest possible score on the CCI-S measure).
Subjective cognitive impairment, information
processing speed, and variability
Processing speed (RT) and IIVRT in SCI and
non-SCI
We predicted that compared to people with no cog-
nitive complaints, individuals with SCI (as defined
by CCI scores) will have slower information pro-
cessing speed (RT) with respect to TMT A, TMT
B, and MILO, and greater IIVRT with respect to the
MILO test, than individuals without SCI. Statistical
analysis however failed to reveal any significant dif-
ferences between groups on information processing
speed with respect to TMT A, TMT B, MILO RT
scores, or MILO IIVRT scores (all p-values >0.05)
(see Supplementary Table 1 for detail).
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Fig. 2. Distribution of CCI-S scores within the non-SCI group.
Fig. 3. Distribution of CCI-S scores within the SCI group.
Within-group relationships
There were no significant within-group correla-
tions between CCI-S scores, RT, and IIVRT in the non-
SCI group (all p values >0.05) (see Supplementary
Table 2 for details).Within the SCI group, however,
the time taken to perform TMT B was significantly
positively correlated to CCI-S score, i.e., the higher
the CCI-S score (indicating worse perceived cog-
nitive functioning), the slower the RT (rs = 0.35, p
(1-tailed) <0.01) (Fig. 4). Furthermore, within the
SCI group, a significant positive correlation between
Fig. 4. Distribution of TMT B scores in the SCI and non-SCI
group.
Fig. 5. Distribution of MILO IIVRT scores in the SCI and non-SCI
group.
CCI-S scores and MILO IIVRT (rs = 0.34, p (1-tailed)
<0.01) was revealed (i.e., worse perceived cogni-
tive functioning was related to greater RT variability)
(Fig. 5). This remained significant after Bonferroni
correction (p= 0.010). Figures 4 and 5 also reveal
that a proportion of individuals showed dispropor-
tional slowing (RT) and greater variability (IIVRT)
only in the SCI group. This is shown by the outliers
in RT and IIVRT, which appear in the SCI group only.
Subjective cognitive impairment, general
cognitive functioning, depression, anxiety, QOL,
memory, and neuroticism
Between-group differences
There were no significant differences in per-
formance on general cognitive functioning, visual
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and verbal memory, or the social relationship QOL
sub-scale (all p values >0.05) between the SCI
and non-SCI groups (see Supplementary Table 3
for details). However, there were significant differ-
ences between these two groups regarding physical
(U = 709.00 (Z = –3.63), p< 0.01), psychological
(U = 728.50 (Z = –3.51), p< 0.01), and environmental
(U = 764.50 (Z = –3.26), p< 0.01) QOL (all moderate
effect size). There were also significant differences on
anxiety (U = 670.50 (Z = –3.881), p< 0.01; Cohen’s
effect size: –0.39 moderate), depression (U = 806.00
(Z = –2.947), p< 0.01; Cohen’s effect size: –0.30
moderate), and neuroticism (U = 822.00 (Z = –2.809),
p< 0.01). Overall, the SCI group demonstrated
poorer perceived physical, psychological, and envi-
ronmental QOL; poorer scores on anxiety and
depression; and higher levels of neuroticism respec-
tively compared to the non-SCI group.
Within-group relationships
There were no within-group correlations in the
non-SCI group between CCI-S scores and any of the
variables (i.e., general cognitive functioning, mem-
ory, QOL, anxiety, depression, and neuroticism).
However, in the SCI group, there were within-group
correlations between CCI-S scores and performance
on visual (rs = –0.38, p (1-tailed) <0.01) and verbal
(rs = –0.34, p (1-tailed) <0.05) memory, physi-
cal (rs = –0.30, p (1-tailed) <0.05), psychological
(rs = –0.37, p (1-tailed) <0.01), and environmen-
tal (rs = –0.24, p (1-tailed) <0.05) QOL, anxiety
(rs = 0.39, p (1-tailed) <0.01), depression (rs = 0.45,
p (1-tailed) <0.01), and neuroticism (rs = 0.26, p (1-
tailed) <0.05). Thus, within the SCI group, poorer
CCI-S scores were correlated with poorer visual and
verbal memory; poorer physical, psychological, and
environmental QOL; worse anxiety and depression;
and higher scores on neuroticism. However, after
Bonferroni correction on the QOL sub-scales, the
only significant within-group correlation to remain
was in relation to psychological QOL.
Further analyses: Subjective cognitive
impairment, slower information processing
speed (RT: TMT B), greater IIVRT, worse levels
of anxiety and depression in the SCI group
The only measure of information processing speed
(RT) that was significantly correlated with CCI-S
scores in the SCI group was TMT B. Also, in rela-
tion to variability, IIVRT was significantly correlated
with CCI-S scores in the SCI group. Therefore, fur-
ther analyses were run to investigate whether TMT
B and IIVRT performance was significantly related to
anxiety and depression.
Statistical analysis revealed that IIVRT was not sig-
nificantly related to anxiety (rs = 0.20, p> 0.05) or
depression (rs = 0.04, p> 0.05) scores. In relation to
RT, a significant positive correlation was identified
between higher scores on anxiety and poorer TMT
B score (higher score, i.e., slower information pro-
cessing speed) (rs = 0.34, p (1-tailed) <0.01) in those
with SCI. This suggests that worse anxiety symptoms
are associated with slower information processing
with respect to TMT B test performance and worse
scores on the CCI-S measure (i.e., slowing associ-
ated with greater perceived feelings of poor cognitive
functioning). After Bonferroni correction ( level
0.05/2 = 0.025), this remained significant (p= 0.010).
In addition, statistical analysis revealed that there
was no significant correlation between TMT B and
depression (rs = 0.15, p (1-tailed) >0.05).
DISCUSSION
The aim of this study was to examine visual
attention-related processing speed (RT), the intra-
individual variability of reaction time (IIVRT),
general cognitive functioning, memory, depression,
anxiety, quality of life, and neuroticism in SCI in
order to improve knowledge of its characteristics and
thus of its potential signs and symptoms.
Contrary to our prediction that individuals with
SCI would show greater slowing in information pro-
cessing speed (RT) and greater IIVRT variability
compared to those without SCI, there was no sig-
nificant difference in mean RT or IIVRT between
these groups, with respect to the TMT A and B or
the MILO test. SCI per se does not therefore appear
characterized by slowing and raised IIVRT. However,
within-group investigation revealed that in the SCI
group only was a proportion of individuals showing
disproportional slowing (RT) and greater variability
(IIVRT). This is clearly demonstrated by the outliers
in RT and IIVRT, which are present only within the
SCI group. For some individuals therefore, SCI is
associated with slowed and/or more variable informa-
tion processing speed and some individuals with SCI
may therefore experience greater deficits in behav-
iors and activities of daily living associated with such
measures (e.g., driving [25]). Furthermore, again for
the SCI group only, CCI-S scores were significantly
correlated with TMT B performance, not with TMT
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A, and MILO RT. Such a pattern of results indi-
cates that although slowing (with respect to certain
tasks and therefore brain processes recruited) may
be related to psychological differences (e.g., anx-
iety), it may also represent a predictor of further
decline as slowed RT and increased IIVRT can be
characteristics of MCI and AD [31–40]. However, the
cross-sectional design of the current study precludes
such analysis.
As predicted, levels of anxiety, depression, and
neuroticism were significantly greater in the SCI
compared to the non-SCI group, and QOL (all forms)
was significantly poorer in the SCI group. Again, in
the SCI but not the non-SCI group, CCI-S scores were
significantly correlated with visual and verbal mem-
ory, anxiety, depression, physical, environmental, and
psychological QOL.
This suggests that some individuals with SCI can
be disproportionately slowed and variable in their
responses indicating that individuals with SCI should
be investigated beyond the findings of general objec-
tive outcome in currently used psychological tests.
These results further highlight the need for a strati-
fied and person-centered approach to SCI, rather than
simply comparing effects at group level particularly
with respect to its possibly detrimental influence upon
an individuals’ daily life and its potential to represent
early neurodegenerative disease.
Level of SCI, MoCA score
To reiterate, the population sample in the present
study was not a clinical one but represented instead
those living within the community who experience
poorer perceived cognition but do not approach mem-
ory services or general practitioners about it. As can
be seen in (Fig. 3), the distribution of CCI-S scores
in the SCI group is positively skewed, i.e., scores are
loaded close to the group cut-off point (i.e., towards
the non-SCI group distribution scores). This skewed
distribution may represent the fact that individuals in
the study tended to experience relatively low levels
of cognitive decline compared to those who approach
memory services or their GP and this fact could pro-
vide an explanation for the lack of significant group
differences (SCI and non-SCI) in relation to TMT A,
TMT B, MILO RT, and MILO IIVRT scores.
Importantly, the main group-differences and
within-group correlations previously summarized
were evident despite normal MoCA scores indicat-
ing that SCI should not be dismissed as unimportant
by testing and diagnosis based solely on general cog-
nitive screening tools. This is further supported by the
results of Reisberg et al. [2] which revealed that 54%
of individuals with SCI declined to MCI or AD but
that the average Mini-Mental State Examination [82]
baseline scores for those who declined was 29 out of a
maximum 30. In a clinical setting therefore, individ-
uals with SCI, who would typically score normally
on such measures, would most likely have been pre-
cluded from further investigation and follow up (see
Jenkins et al. [28]).
Memory
As predicted, in the non-SCI group there were no
significant correlations between CCI-S, HVLT (ver-
bal), and ROCF (visual) scores. In the SCI group,
however, both the HVLT and ROCF scores were sig-
nificantly negatively correlated with CCI-S scores.
The correlation between ROCF and CCI-S scores
was stronger and had a greater effect size than that
between HVLT and CCI-S scores. These results sug-
gest that within the SCI group greater degrees of
subjective impairment are associated with poorer
visual/non-verbal memory and verbal recognition.
This finding provides support for past research (i.e.,
see [83–85]) indicating that impairments in episodic
memory are characteristic of SCI, although there are
also inconsistencies in such research findings [86].
Neuroticism
Neuroticism was significantly greater in the SCI
compared to the non-SCI group. Furthermore, within
the SCI, but not the non-SCI group, neuroticism
was significantly correlated with CCI-S score. These
results are in alignment with those of Ausen et al.
[66] in that a high level of neuroticism may represent
a risk factor for experiencing cognitive impairment
and for further decline [54, 66, 69].
Affective symptoms
As expected, anxiety and depression (specifically
sub-clinical depression, thus low mood) scores were
significantly poorer for the SCI compared to the non-
SCI groups. Within the SCI group only, CCI-S score
(i.e., poorer SCI scores) was significantly correlated
with both higher levels of anxiety and depression
(sub-clinical) [8], although directional causality [25,
62, 88–92] could not be ascertained in the current
study.
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Affective symptoms, RT and IIVRT
Further analyses were run on the significant
relationship found between anxiety and TMT B
performance. A significant positive correlation was
found between TMT B performance and anxiety,
thus slower RT was associated with greater levels
of anxiety indicating that processing speed on the
TMT B could be associated with anxiety for those
in the SCI group. No significant correlation was
found between TMT B performance and sub-clinical
depression scores. Despite the commonly identified
co-morbid relationship between anxiety and depres-
sion [60], these results indicate that anxiety may
have more impact on RT compared to depression.
The identified increase in negative affective symp-
toms and related slowing in the SCI group supports
the recommendation by Jessen et al. [21] to not dis-
miss such sub-threshold symptoms, to ensure they
are considered when assessing for cognitive decline
(specifically SCD).
Quality of life
After Bonferroni correction, only psychological
QOL was significantly correlated with CCI-S scores
within the SCI group, thus indicating that SCI may
be particularly associated with psychological factors,
again of course causality cannot be determined here
[23, 24]. Also, our finding of significantly higher lev-
els of anxiety in the SCI group is in agreement with
Strine and colleagues [93] who found that individuals
with higher levels of self-reported anxiety were more
likely to have poorer levels of health-related QOL
[93]. Therefore, there may be an association between
poor SCI, poor anxiety, and poor QOL.
Despite the inability to determine causality and
loss of post correction significance, what the current
study does highlight is that a characteristic of SCI is
a diminished sense of psychological QOL. To con-
clude, a number of variables measured appeared to
characterize SCI in comparison to those without SCI.
At group level, individuals with SCI were more likely
to have higher scores on anxiety, depression (specif-
ically low mood), and neuroticism, together with
worse perceived physical, psychological, and envi-
ronmental QOL. Correlational analysis identified no
significant relationships between any of the variables
within the non-SCI group. However, in the SCI group,
there were a number of meaningful correlations iden-
tified with CCI-S data, thus, RT (TMT B) and IIVRT
(MILO), verbal memory, non-verbal/visual memory,
anxiety, depression (specifically low mood), neuroti-
cism, and QOL.
Study limitations and future research
It is questionable whether a larger sample would
have produced similar or different results. The sample
size was determined based on past research studies
of attention related RT tests, in MCI and AD, with
typical numbers approximately between 20 and 30
participants. Since the relationship between SCI and
RT (in the general public) has not been investigated
using such studies and because the effects in SCI may
be smaller than in MCI and AD, the number of par-
ticipants in the present study was increased in each
group to 50.
The fundamental aim of this study was to highlight
potential SCI characteristics in a normal population
and irrespective of etiology, and its cross-sectional
design thus rendered it impossible to determine
causal relationships and any relationship between the
findings and the development of MCI or dementia, or
the successful treatment of SCI. These are areas for
further and longitudinal investigation; factors beyond
the scope of the present study [23, 94].
This study has provided a valuable contribution to
research regarding the characterization of SCI in the
general population. It is clear that despite the sam-
ple having a low level of cognitive impairment, they
were still reporting poorer scores in relation to anx-
iety, depression, and QOL. Regardless of whether
the SCI symptoms are a cause or consequence of
such distress, their cognitive concerns should not be
dismissed as benign. Thus, appropriate SCI manage-
ment might enable potentially reversible symptoms
to be treated (e.g., psychological difficulties), there-
fore not only possibly alleviating SCI symptoms but
also decreasing the risk of further cognitive decline
[60].
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